New diabetes clinical trial: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Published on: June 30, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: HDM1002 50 mg; Drug: HDM1002 100 mg; Drug: HDM1002 200 mg; Drug: HDM1002 400 mg; Drug: HDM1002 200 mg BID; Drug: Placebo
Sponsors: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Not yet recruiting